Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,126 followers.

Comparative #Effectiveness of #Umeclidinium/ #Vilanterol versus #Inhaled #Corticosteroid/Long-Acting β2-Agonist in #Patients with #Chronic #Obstructive #Pulmonary #Disease in a Primary Care Setting in England #COPD https://t.co/rSruqnpNPF https://t.co/28ye

14 May 2023

Reply Repost Favourite

Umeclidinium/vilanterol versus inhaled corticosteroid | COPD - Dove Medical Press https://t.co/qk1NHPC1vu PDC represented proportion of time over the treatment duration that the patient ... making it the second most common lung disease after asthma.

19 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.